mutations and complicated kar yotype. It follows a linear evolution through the CLL clone from the recurrent acquisition of CDKN2ANot all patients with CLL call for therapy. Even with all the latest advancements, the iwCLL however suggests watchful observation for individuals with asymptomatic disorder.86 This advice is based on at the very least t